NCT00433108View on ClinicalTrials.gov

Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2007

Study Completion Date

November 30, 2007

Conditions
Chronic Hepatitis C
Interventions
DRUG

Mitoquinone mesylate (MitoQ)

Trial Locations (2)

Unknown

New Zealand Liver Unit, Auckland City Hospital, Auckland

Waikato Hospital, Hamilton

Sponsors
All Listed Sponsors
lead

Antipodean Pharmaceuticals, Inc.

INDUSTRY

NCT00433108 - Trial of MitoQ for Raised Liver Enzymes Due to Hepatitis C | Biotech Hunter | Biotech Hunter